Skip to content
Screener

Absci Corporation ABSI Shares (Diluted)

Shares (Diluted) at other companies

Schrodinger logo
SchrodingerSDGR
75.8M+3.2%
Recursion Pharmaceuticals, Inc. logo
Recursion Pharmaceuticals, Inc.RXRX
532.5M+27.6%
Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE
78.5M+30.3%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
305.6M+2.4%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
28.7M-6.4%
Assembly Biosciences logo
Assembly BiosciencesASMB
16.9M+125%

Other financials

Income statement

See full
Revenue$318.0K-46.4%
Operating income-$34.2M-8.8%
Net income-$33.2M-8.6%
EPS (diluted)-$0.21+12.5%

Balance sheet

See full
Cash & equivalents$108.9M+97.0%
Total debt$3.7M-32.2%
Total equity$246.1M+42.0%
Total assets$268.9M+28.1%

Cash flow

See full
Operating cash flow-$27.6M-63.4%
CapEx$1.0K-99.6%
Free cash flow-$27.6M-61.2%

Valuation

See full
Market cap$1.51B+271%
Enterprise value$1.41B+293%
P/S969.1×+871×

Profitability

See full
Operating margin-8,084.5%-17,708pp
Net margin-7,756.4%-17,069pp
FCF margin-6,981%-10,936pp

Returns & leverage

See full
Return on equity-57.7%+0.3pp
Debt / equity0.0×
Current ratio10.6×+6.2×

Where this comes from

Reported directly by Absci Corporation in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The source filing: Absci Corporation’s 10-Q, filed August 11, 2026.

Filed
Aug 11, 2026, 4:08 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001672688-26-000136
(In thousands, except for share and per share data)For the Three Months Ended June 30, 2026For the Three Months Ended June 30, 2025For the Six Months Ended June 30, 2026For the Six Months Ended June 30, 2025
Income tax expense(40)(131)(58)(127)
Net loss$(33,210)$(30,569)$(62,809)$(56,915)
Net loss per share:Basic and diluted$(0.21)$(0.24)$(0.40)$(0.45)
Weighted-average common shares outstanding:Basic and diluted157,471,712127,592,948155,217,585126,035,844
Comprehensive loss:
Net loss$(33,210)$(30,569)$(62,809)$(56,915)
Foreign currency translation adjustments(52)324(117)401
Unrealized loss on marketable securities(102)(32)(324)(86)

Item 1. Unaudited Condensed Consolidated Financial Statements

FAQ

What is Absci Corporation's shares (diluted)?
Absci Corporation (ABSI) reported shares (diluted) of 157.5M in Q2 2026.
How has Absci Corporation's shares (diluted) changed year-over-year?
Absci Corporation's shares (diluted) increased by 23.4% year-over-year, from 127.6M to 157.5M.
What is the long-term trend for Absci Corporation's shares (diluted)?
Over 4 years (2021 to 2025), Absci Corporation's shares (diluted) has grown at a 35.6% compound annual growth rate (CAGR), from 157.6M to 532.6M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.

Ask your AI about Absci Corporation's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude